The U.S. Food and Drug Administration approved Dalvance (dalbavancin), a new antibacterial drug for treatment of skin infections in adults.
Read the full article on Becker's Hospital Review.
Read the full article on Becker's Hospital Review.
FDA Approves Dalvance for Adult Skin Infection Treatments
Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.
